معرفی
Elias Arnér is a Professor in biochemistry at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet. He holds roles such as Director of Cancer Research KI (CRKI) since 2024, member of the Nobel Assembly, and former Dean of Postgraduate Education (2005-2007). His research focuses on selenoproteins, thioredoxin systems, and redox signaling in health and disease, with applications in cancer therapy and biotechnology.
- Education: MD and PhD from Karolinska Institutet (1993/1997), postdoc at Ludwig Maximilian University (1998-1999).
- Research Interests: Selenoprotein function, thioredoxin reductase inhibition in cancer, and development of selenoprotein-based therapeutics. Key areas include selenium's role in antioxidant systems, redox regulation, and cancer cell signaling.
- Grants: Multiple grants from Swedish Research Council, Swedish Cancer Society, and Knut and Alice Wallenberg Foundation for projects on selenoproteins and cancer redox pathways.
- Labs/Teams: Leads the Elias Arnér research group, collaborating with institutions in Hungary, Italy, and the U.S. on projects like thioredoxin reductase inhibitors and selenoprotein production systems.
۰مقاله منتشرشده
